ChEMBL ID: CHEMBL2109191
Mechanism of action: T-lymphocyte activation antigen CD80 inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to GALIXIMAB